DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $28,483,169 | -1.6% | 1,024,206 | +8.6% | 0.01% | -12.5% |
Q3 2022 | $28,953,069 | +18.3% | 943,404 | +13.4% | 0.01% | +33.3% |
Q2 2022 | $24,480,139 | -10.1% | 831,809 | -1.7% | 0.01% | 0.0% |
Q1 2022 | $27,217,847 | -27.9% | 846,063 | -0.0% | 0.01% | -25.0% |
Q4 2021 | $37,736,000 | -12.3% | 846,109 | -0.8% | 0.01% | -20.0% |
Q3 2021 | $43,052,000 | -26.0% | 853,356 | +15.0% | 0.01% | -23.1% |
Q2 2021 | $58,201,000 | +70.5% | 741,980 | +24.1% | 0.01% | +62.5% |
Q1 2021 | $34,132,000 | -52.4% | 597,766 | -30.2% | 0.01% | -52.9% |
Q4 2020 | $71,734,000 | +120.9% | 856,429 | -5.5% | 0.02% | +88.9% |
Q3 2020 | $32,475,000 | +44.0% | 906,373 | -2.8% | 0.01% | +50.0% |
Q2 2020 | $22,550,000 | +35.8% | 932,579 | -1.7% | 0.01% | 0.0% |
Q1 2020 | $16,609,000 | +52.9% | 948,538 | +52.1% | 0.01% | +100.0% |
Q4 2019 | $10,862,000 | +13.7% | 623,538 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $9,553,000 | -20.0% | 623,538 | +8.4% | 0.00% | -25.0% |
Q2 2019 | $11,947,000 | -10.6% | 575,462 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $13,362,000 | +155.5% | 575,462 | +116.7% | 0.00% | +100.0% |
Q1 2018 | $5,230,000 | -48.6% | 265,616 | -59.1% | 0.00% | -50.0% |
Q4 2017 | $10,166,000 | – | 650,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 5,960,732 | $122,969,901 | 14.32% |
ARCH Venture Management, LLC | 693,749 | $14,312,042 | 9.30% |
Flagship Pioneering Inc. | 2,619,968 | $54,049,940 | 3.92% |
Casdin Capital, LLC | 1,300,000 | $26,819,000 | 2.97% |
Yiheng Capital Management, L.P. | 1,150,684 | $23,738,611 | 1.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 154,000 | $3,172,400 | 1.07% |
SECTORAL ASSET MANAGEMENT INC | 254,941 | $5,259,433 | 1.02% |
Temasek Holdings (Private) Ltd | 6,895,992 | $142,264,315 | 0.85% |
Clarius Group, LLC | 378,262 | $7,803,545 | 0.74% |
Artal Group S.A. | 802,899 | $16,564 | 0.71% |